Causality between heart failure and epigenetic age: a bidirectional Mendelian randomization study

ESC Heart Fail. 2023 Oct;10(5):2903-2913. doi: 10.1002/ehf2.14446. Epub 2023 Jul 14.

Abstract

Aims: Heart failure (HF) is a prevalent age-related cardiovascular disease with poor prognosis in the elderly population. This study aimed to establish the causal relationship between ageing and HF by conducting a bidirectional Mendelian randomization (MR) analysis on epigenetic age (a marker of ageing) and HF.

Methods and results: Genome-wide association study data for epigenetic age (GrimAge, HorvathAge, HannumAge, and PhenoAge) and HF were collected and assessed for significant genetic variables. A bidirectional MR analysis was carried out using the random-effects inverse-variance weighted (IVW) method as the primary approach, while other methods (MR-Egger, weighted median, simple mode, and weighted mode) and multiple sensitivity analyses (heterogeneity analysis, leave-one-out sensitivity analysis, and horizontal pleiotropy analysis) were employed to evaluate the impact of epigenetic age on HF and vice versa. Bidirectional MR analysis of two samples revealed that the epigenetic PhenoAge clock increased the risk of HF [IVW odds ratio (OR) 1.015, 95% confidence interval (CI) 1.002-1.028, P = 0.028 and weighted median OR 1.020, 95% CI 1.001-1.038, P = 0.039]. Other results were not statistically significant.

Conclusions: The bidirectional MR analysis demonstrated a causal link between genetically predicted epigenetic age and HF in individuals of European descent. Further research into epigenetic age in other populations and additional genetic information related to HF is warranted.

Keywords: Bidirectional Mendelian randomization (MR) study; Causality; Epigenetic age; Genome-wide association study (GWAS); Heart failure (HF).

MeSH terms

  • Aged
  • Aging / genetics
  • Epigenesis, Genetic*
  • Genome-Wide Association Study*
  • Heart Failure* / epidemiology
  • Heart Failure* / genetics
  • Humans
  • Mendelian Randomization Analysis*
  • Polymorphism, Single Nucleotide
  • Prognosis
  • Risk Factors